doi: 10.3389/fphar.2025.1602976 Received 30 March 2025 Revised 13 November 2025 Accepted 14 November 2025 Published 19 December 2025 Volume 16 - 2025 Edited by Bernd Rosenkranz, Fundisa African Academy of Medicines Development, South Africa Reviewed by Kacper Nijakowski, Poznan University of Medical Sciences, Poland Miriam Njoki Karinja, Science for Africa Foundation, Kenya Updates Copyright 2025 Mazur, Ndokaj, Salerno, Vallone, Ardan, Bietolini, Carrouel, Wilk, Sarig, Ottolenghi and Bourgeois
The FDA-approved package insert describes one of the steps for administering Luxturna as, after completing a vitrectomy, identify the intended site of administration
Low B12 levels can contribute to fatigue, weakness, anemia, and neurological symptoms
International research institutions often require specific paperwork for peptide imports
100 mM) which served as the control
It is also used in the management of neuropathic pain and diabetic neuropathy, providing support for neurological disorders involving nerve degeneration